U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
86413
Name Type Language
CATRIDECACOG
INN   WHO-DD  
INN  
Official Name English
HUMAN RECOMBINANT FACTOR XIII SUBUNIT A DIMER
Common Name English
COAGULATION FACTOR XIII A SUBUNIT (RECOMBINANT)
Common Name English
COAGULATION FACTOR XIII A-SUBUNIT RECOMBINANT
Common Name English
RECOMBINANT COAGULATION FACTOR XIII A-SUBUNIT
Common Name English
CATRIDECACOG (GENETICAL RECOMBINATION)
JAN  
Official Name English
TRETTEN
Brand Name English
CATRIDECACOG [JAN]
Common Name English
HUMAN FACTOR XIII (A2) HOMODIMER (ALLELE F13A*1B), RECOMBINANT DNA ORIGIN
Common Name English
BLOOD-COAGULATION FACTOR XIII (SYNTHETIC HUMAN A-CHAIN PRECURSOR), DIMER
Common Name English
Catridecacog [WHO-DD]
Common Name English
RECOMBINANT COAGULATION FACTOR XIII
Common Name English
COAGULATION FACTOR XIII RECOMBINANT HUMAN
Common Name English
catridecacog [INN]
Common Name English
NOVOTHIRTEEN
Brand Name English
Classification Tree Code System Code
WHO-VATC QB02BD11
Created by admin on Sat Dec 16 01:38:20 UTC 2023 , Edited by admin on Sat Dec 16 01:38:20 UTC 2023
WHO-ATC B02BD11
Created by admin on Sat Dec 16 01:38:20 UTC 2023 , Edited by admin on Sat Dec 16 01:38:20 UTC 2023
FDA ORPHAN DRUG 174803
Created by admin on Sat Dec 16 01:38:20 UTC 2023 , Edited by admin on Sat Dec 16 01:38:20 UTC 2023
EMA ASSESSMENT REPORTS NOVOTHIRTEEN (AUTHORIZED:CONGENITAL FACTOR XIII A-SUBUNIT DEFICIENCY)
Created by admin on Sat Dec 16 01:38:20 UTC 2023 , Edited by admin on Sat Dec 16 01:38:20 UTC 2023
FDA ORPHAN DRUG 73993
Created by admin on Sat Dec 16 01:38:20 UTC 2023 , Edited by admin on Sat Dec 16 01:38:20 UTC 2023
FDA ORPHAN DRUG 168603
Created by admin on Sat Dec 16 01:38:20 UTC 2023 , Edited by admin on Sat Dec 16 01:38:20 UTC 2023
Code System Code Type Description
WIKIPEDIA
Catridecacog
Created by admin on Sat Dec 16 01:38:20 UTC 2023 , Edited by admin on Sat Dec 16 01:38:20 UTC 2023
PRIMARY
CAS
606138-08-3
Created by admin on Sat Dec 16 01:38:20 UTC 2023 , Edited by admin on Sat Dec 16 01:38:20 UTC 2023
PRIMARY
ChEMBL
CHEMBL2108282
Created by admin on Sat Dec 16 01:38:20 UTC 2023 , Edited by admin on Sat Dec 16 01:38:20 UTC 2023
PRIMARY
FDA UNII
NU23Q531G1
Created by admin on Sat Dec 16 01:38:20 UTC 2023 , Edited by admin on Sat Dec 16 01:38:20 UTC 2023
PRIMARY
RXCUI
1488293
Created by admin on Sat Dec 16 01:38:20 UTC 2023 , Edited by admin on Sat Dec 16 01:38:20 UTC 2023
PRIMARY
SMS_ID
100000124525
Created by admin on Sat Dec 16 01:38:20 UTC 2023 , Edited by admin on Sat Dec 16 01:38:20 UTC 2023
PRIMARY
JAPANESE REVIEW
NOVOTHIRTEEN
Created by admin on Sat Dec 16 01:38:20 UTC 2023 , Edited by admin on Sat Dec 16 01:38:20 UTC 2023
PRIMARY APPROVED MARCH 2015
DAILYMED
NU23Q531G1
Created by admin on Sat Dec 16 01:38:20 UTC 2023 , Edited by admin on Sat Dec 16 01:38:20 UTC 2023
PRIMARY
NCI_THESAURUS
C174766
Created by admin on Sat Dec 16 01:38:20 UTC 2023 , Edited by admin on Sat Dec 16 01:38:20 UTC 2023
PRIMARY
INN
8817
Created by admin on Sat Dec 16 01:38:20 UTC 2023 , Edited by admin on Sat Dec 16 01:38:20 UTC 2023
PRIMARY
EVMPD
SUB32158
Created by admin on Sat Dec 16 01:38:20 UTC 2023 , Edited by admin on Sat Dec 16 01:38:20 UTC 2023
PRIMARY
DRUG BANK
DB09310
Created by admin on Sat Dec 16 01:38:20 UTC 2023 , Edited by admin on Sat Dec 16 01:38:20 UTC 2023
PRIMARY
DRUG CENTRAL
5134
Created by admin on Sat Dec 16 01:38:20 UTC 2023 , Edited by admin on Sat Dec 16 01:38:20 UTC 2023
PRIMARY
ACTIVE MOIETY
CATRIDECACOG
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966